Petpharm
PrivateLast Round
Series B
May 8, 2025
Est. Valuation
$3.04M
Total Funding Raised
$7.77M
Company Overview
Petpharm operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in May 2025.
Petpharm is a veterinary pharmaceutical company that operates a B2B platform for veterinary pharmacies and manufactures animal healthcare products.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology, E-commerce, Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Marketplace Commission
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Petpharm Comparables
Compare Petpharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vet-Nine | 77% | |
| VetTec Korea | 71% | |
| KOREA THUMB VET Co., Ltd. | 63% |
For institutional investors. Book with your work email.
Petpharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 8, 2025 | ||||
| Series A | Aug 8, 2023 | ||||
| Pre Seed | Dec 2, 2021 | ||||
| Crowdfunding | Oct 21, 2021 |
For institutional investors. Book with your work email.
Petpharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eugene Asset Management | Series B, Series A |
| Banks Foundation for Young Entrepreneurs | Series B |
| CRIT Ventures | Series B |
| STIC Ventures | Series B |
| Korea Investment Partners | Series A |
| Korea Credit Guarantee Fund | Series A |
| New Paradigm Investment | Series A, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 8, 2025
$4.55M round led by CRIT Ventures and STIC Ventures.
- Aug 8, 2023
$2.56M round led by Korea Investment Partners.
For institutional investors. Book with your work email.
Petpharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Petpharm's valuation, stock price, and market status.
Is Petpharm a public or private company?
Petpharm is a private company.
What is the current stock price of Petpharm?
Petpharm is a private company, so its shares have no public market price. Caplight tracks Petpharm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Petpharm worth (valuation)?
Petpharm's valuation is estimated at $3.0M based on funding round data.
Can I buy Petpharm stock?
Petpharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Petpharm's last funding round?
Petpharm's most recent funding round was Series B on May 8, 2025.
Who are the main investors in Petpharm?
Key investors in Petpharm include Korea Investment Partners.
Will Petpharm IPO soon?
No public IPO plans have been announced for Petpharm.
How can I track Petpharm secondary market activity?
Caplight tracks bids, offers, and trades in Petpharm's shares on secondary markets.